Your browser doesn't support javascript.
loading
Combined berberine and probiotic treatment as an effective regimen for improving postprandial hyperlipidemia in type 2 diabetes patients: a double blinded placebo controlled randomized study.
Wang, Shujie; Ren, Huahui; Zhong, Huanzi; Zhao, Xinjie; Li, Changkun; Ma, Jing; Gu, Xuejiang; Xue, Yaoming; Huang, Shan; Yang, Jialin; Chen, Li; Chen, Gang; Qu, Shen; Liang, Jun; Qin, Li; Huang, Qin; Peng, Yongde; Li, Qi; Wang, Xiaolin; Zou, Yuanqiang; Shi, Zhun; Li, Xuelin; Li, Tingting; Yang, Huanming; Lai, Shenghan; Xu, Guowang; Li, Junhua; Zhang, Yifei; Gu, Yanyun; Wang, Weiqing.
Afiliación
  • Wang S; Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Ren H; Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the Pr China, Shanghai National Center for Translational Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai,
  • Zhong H; BGI-Shenzhen, Shenzhen, China.
  • Zhao X; Laboratory of Genomics and Molecular Biomedicine, Department of Biology, University of Copenhagen, Copenhagen, Denmark.
  • Li C; BGI-Shenzhen, Shenzhen, China.
  • Ma J; Dalian Institute of Chemical Physics, Chinese Academy of Science, Dalian, China.
  • Gu X; Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Xue Y; Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the Pr China, Shanghai National Center for Translational Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai,
  • Huang S; Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Yang J; Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Chen L; Department of Endocrinology, The First Affiliated Hospital of Wenzhou Medical University, Zhejiang Province, China.
  • Chen G; Nanfang Hospital, Southern Medical University, Guangdong Province, China.
  • Qu S; Tong Ren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Liang J; Department of Endocrinology, Central Hospital of Minhang District, Shanghai, China.
  • Qin L; Department of Endocrinology, Qilu Hospital of Shandong University, Shandong Province, China.
  • Huang Q; Department of Endocrinology, Fujian Provincial Hospital, Fujian Province, China.
  • Peng Y; Department of Endocrinology, Shanghai Tenth People's Hospital of Tong Ji University, Shanghai, China.
  • Li Q; Department of Endocrinology, Xuzhou Central Hospital, Jiangsu Province, China.
  • Wang X; Xin Hua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Zou Y; Chang Hai Hospital, Second Military Medical University, Shanghai, China.
  • Shi Z; Shanghai First People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Li X; Dalian Institute of Chemical Physics, Chinese Academy of Science, Dalian, China.
  • Li T; Dalian Institute of Chemical Physics, Chinese Academy of Science, Dalian, China.
  • Yang H; BGI-Shenzhen, Shenzhen, China.
  • Lai S; BGI-Shenzhen, Shenzhen, China.
  • Xu G; Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Li J; Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the Pr China, Shanghai National Center for Translational Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai,
  • Zhang Y; Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Gu Y; Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the Pr China, Shanghai National Center for Translational Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai,
  • Wang W; BGI-Shenzhen, Shenzhen, China.
Gut Microbes ; 14(1): 2003176, 2022.
Article en En | MEDLINE | ID: mdl-34923903
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Métodos Terapéuticos y Terapias MTCI: Plantas_medicinales Asunto principal: Berberina / Probióticos / Diabetes Mellitus Tipo 2 / Hiperlipidemias Tipo de estudio: Clinical_trials Idioma: En Revista: Gut Microbes Año: 2022 Tipo del documento: Article País de afiliación: China
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Métodos Terapéuticos y Terapias MTCI: Plantas_medicinales Asunto principal: Berberina / Probióticos / Diabetes Mellitus Tipo 2 / Hiperlipidemias Tipo de estudio: Clinical_trials Idioma: En Revista: Gut Microbes Año: 2022 Tipo del documento: Article País de afiliación: China